Skip to main content

Advertisement

SpringerLink
Log in

Infection-related morbidity and mortality in patients with connective tissue diseases: a systematic review

  • Review
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

Patients suffering from connective tissue diseases (CTDs) constitute an important subgroup of immunosuppressed patients at risk for developing serious infections. Prophylactic antibiotic administration may decrease infection-related morbidity and mortality burden in patients with CTD, though one needs first to evaluate the overall effect of infection on morbidity and mortality in such patients and the presence of adequate prognostic/risk factors for infection development. Studies focusing on infection-related morbidity and mortality in patients with CTD were reviewed. Data on disease type, therapeutic regimens used, including corticosteroid dose and method of administration as well as other immunosuppressive agents, and outcome were extracted to evaluate the existence of specific treatment patterns predisposing to infection as well as infectious disease-related morbidity and mortality in patients with CTD. Thirty-nine studies focusing on infection incidence and/or outcome in patients with CTD were identified and analyzed; the majority of the reviewed studies (20) included patients with systemic lupus erythematosus (SLE). The mortality attributed to infection was 5.2%, while the overall mortality was 20%. There were no adequate data on the specific effect patterns of corticosteroid and immunosuppressant treatment on infection risk. Pneumocystis jiroveci (carinii) pneumonia, evaluated independently, exhibited significant mortality in patients with Wegener’s granulomatosis, polymyositis/dermatomyositis, and SLE. In conclusion, infectious diseases are a major cause of mortality in patients with CTD. However, treatment-related factors predisposing to serious infections have not been adequately outlined. In addition, there are no data regarding the effect of prophylactic practices involving antibiotic administration in morbidity and mortality.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Noel V, Lortholary O, Casassus P, Cohen P, Genereau T, Andre M-H et al (2001) Risk factors and prognostic influence of infection in a single cohort of 87 adults with systemic lupus erythematosus. Ann Rheum Dis 60:1141–1144

    Article  PubMed  CAS  Google Scholar 

  2. Mok CC, Lee KW, Ho CTK, Lau CS, Wong RWS (2000) A prospective study of survival and prognostic indicators of systemic lupus erythematosus in a southern Chinese population. Rheumatology 39:399–406

    Article  PubMed  CAS  Google Scholar 

  3. Jacobsen S, Petersen J, Ullman S, Junker P, Voss A, Rasmussen JM, Tarp U et al (1998) A multicentre study of 513 Danish patients with systemic lupus erythematosus. II. Disease mortality and clinical factors of prognostic value. Clin Rheumatol 17:478–484

    Article  PubMed  CAS  Google Scholar 

  4. Abu-Shakra M, Urowitz MB, Gladman DD, Gough J (1995) Mortality studies in systemic lupus erythematosus. Results from a single center .I. Causes of death. J Rheumatol 22:1259–1264

    PubMed  CAS  Google Scholar 

  5. Abu-Shakra M, Urowitz MB, Gladman DD, Gough J (1995) Mortality studies in systemic lupus erythematosus. Results from a single center. II. Predictor variables for mortality. J Rheumatol 22:1265–1270

    PubMed  CAS  Google Scholar 

  6. Janwityanuchit S, Totemchokchyakarn K, Krachangwongchai K, Vatanasuk M (1993) Infection in systemic lupus erythematosus. J Med Assoc Thai 76:542–548

    PubMed  CAS  Google Scholar 

  7. Nossent JC (1993) Course and prognostic value of systemic lupus erythematosus disease activity index in black Caribbean patients. Semin Arthritis Rheum 23:16–21

    Article  PubMed  CAS  Google Scholar 

  8. Petri M, Genovese M (1992) Incidence of and risk factors for hospitalisations in systemic lupus erythematosus: a prospective study of the Hopkins lupus cohort. J Rheumatol 19:1559–1565

    PubMed  CAS  Google Scholar 

  9. Wong KL (1992) Pattern of SLE in Hong Kong Chinese: A cohort study. Scand J Rheumatol 21:289–296

    PubMed  CAS  Google Scholar 

  10. Breban M, Meyer O, Bourgeois P, Palazzo M, Kahn MF (1991) The actual survival rate in systemic lupus erythematosus: study of a 1976 cohort. Clin Rheumatol 10:283–288

    Article  PubMed  CAS  Google Scholar 

  11. Duffy KN, Duffy CM, Gladman DD (1991) Infection and disease activity in systemic lupus erythematosus: a review of hospitalised patients. J Rheumatol 18:1180–1184

    PubMed  CAS  Google Scholar 

  12. Reveille JD, Bartolucci A, Alarcon GS (1990) Prognosis in systemic lupus erythematosus. Negative impact of increasing age at onset, black race and thrombocytopenia, as well as causes of death. Arthritis Rheum 33:37–48

    Article  PubMed  CAS  Google Scholar 

  13. Halberg P, Alsbjorn B, Baislev JT, Gerstoft J, Lorenzen I, Ullman S et al (1987) Systemic lupus erythematosus. Follow up study of 148 patients. II: Predictive factors of importance for course and outcome. Clin Rheumatol 6:22–26

    Article  PubMed  CAS  Google Scholar 

  14. Halberg P, Alsbjorn B, Baslov JT, Gerstoft J, Lorenzen I, Ullman S et al (1987) Systemic lupus erythematosus: follow up study of 148 patients. I: Classification, clinical and laboratory findings, course and outcome. Clin Rheumatol 6:13–21

    Article  PubMed  CAS  Google Scholar 

  15. Hellmann DB, Petri M, Whiting-O’Keefe Q (1987) Fatal infections in systemic lupus erythematosus: the role of opportunistic organisms. Medicine (Baltimore) 66:341–348

    CAS  Google Scholar 

  16. Nived O, Sturfelt G, Wollheim F, Wollheim F (1985) Systemic lupus erythematosus and infection: a controlled and prospective study including an epidemiological group. Q J Med 55:271–287

    PubMed  CAS  Google Scholar 

  17. Rosner S, Ginzler EM, Diamond HS, Weiner M, Schlesinger M, Fries J et al (1982) A multicenter study of outcome in systemic lupus erythematosus. II. Causes of death. Arthritis Rheum 25:612–617

    Article  PubMed  CAS  Google Scholar 

  18. Wallace DJ, Podell T, Weiner J, Klineberg JR, Forouzesh S, Dubois El (1981) Systemic lupus erythematosus survival patterns. Experience with 609 patients. JAMA 245:934–938

    Article  PubMed  CAS  Google Scholar 

  19. Perez HD, Andron RI, Goldstein IM (1979) Infection in patients with systemic lupus erythematosus. Association with a serum inhibitor of complement-derived chemotactic activity. Arthritis Rheum 22:1326–1333

    Article  PubMed  CAS  Google Scholar 

  20. Ginzler E, Diamond H, Kaplan D, Weiner M, Schlesinger M, Seleznick M (1978) Computer analysis of factors influencing frequency of infection in systemic lupus erythematosus. Arthritis Rheum 21:37–44

    Article  PubMed  CAS  Google Scholar 

  21. Urman JD, Rothfield NF (1977) Corticosteroid treatment in systemic lupus erythematosus. Survival studies. JAMA 238:2272–2276

    Article  PubMed  CAS  Google Scholar 

  22. Lee P, Urowitz MB, Bookman AA, Bookman M, Koehler B, Smythe H et al (1977) Systemic lupus erythematosus. A review of 110 cases with reference to nephritis, the nervous system, infections, aseptic necrosis and prognosis. Q J Med 46:1–32

    PubMed  CAS  Google Scholar 

  23. Schiff MH, DiVittorio G, Tesser J, Fleischmann R, Schechtman J, Hartman S et al (2004) The safety of anakinra in high-risk patients with active rheumatoid arthritis: six-month observations of patients with combined conditions. Arthritis Rheum 50:1752–1760 (Jun)

    Article  PubMed  CAS  Google Scholar 

  24. Hernandez-Cruz B, Cardiel MH, Villa AR, Alcocer-Varela (1998) Development, recurrence and severity of infections in Mexican patients with rheumatoid arthritis. A nested case–control study. J Rheumatol 25:1900–1907

    PubMed  CAS  Google Scholar 

  25. Saag KG, Koehneke R, Caldwell JR, Brasington R, Burmeister LF, Zimmerman B et al (1994) Low dose long-term corticosteroid therapy in rheumatoid arthritis: an analysis of serious adverse events. Am J Med 96:115–123

    Article  PubMed  CAS  Google Scholar 

  26. Reilly PA, Cosh JA, Maddison PJ, Rasker JJ, Silman AJ (1990) Mortality and survival in rheumatoid arthritis: a prospective study of 100 patients. Ann Rheum Dis 49:363–369

    PubMed  CAS  Google Scholar 

  27. Van Albada-Kuipers GA, Linthorst J, Peeters EA, Breedveld FC, Dukmans AC, Hermans J et al (1988) Frequency of infection among patients with rheumatoid arthritis versus patients with osteoarthritis or soft tissue rheumatism. Arthritis Rheum 31:667–671

    Article  PubMed  Google Scholar 

  28. Mitchell D, Spitz P, Young DY, Bloch DA, McShane DJ, Fries JF (1986) Survival, prognosis and causes of death in rheumatoid arthritis. Arthritis and Rheum 29:706–714

    Article  CAS  Google Scholar 

  29. Pincus T, Callahan L, Sale W, Brooks AL, Payne LE, Vaughn WK (1984) Severe functional declines, work disability and increased mortality in seventy-five rheumatoid arthritis patients studied over nine years. Arthritis Rheum 27:864–871

    Article  PubMed  CAS  Google Scholar 

  30. Vandenbroucke JP, Hazevoet HM, Cats A (1984) Survival and cause of death in rheumatoid arthritis: a 25-year prospective follow up. J Rheumatol 11:158–161

    PubMed  CAS  Google Scholar 

  31. Prior BP, Symmons DPM, Scott DL, Brown R, Hawkins CF (1984) Cause of death in rheumatoid arthritis. Br J Rheumatol 23:92–99

    Article  PubMed  CAS  Google Scholar 

  32. Rasker JJ, Cosh JA (1981) Cause and age of death in a prospective study of 100 patients with rheumatoid arthritis. Ann Rheum Dis 40:115–120

    Article  PubMed  CAS  Google Scholar 

  33. Koota K, Isomaki, Mutru O (1977) Death rate and causes of death in RA patients during a period of five years. Scand J Rheumatol 6:241–244

    PubMed  CAS  Google Scholar 

  34. Marie I, Hachulla E, Cherin P, Hellot MF, Herson S, Levesque H et al (2005) Opportunistic infections in Polymyositis and Dermatomyositis. Arthritis Rheum 53:155–165

    Article  PubMed  Google Scholar 

  35. Sultan SM, Ioannou Y, Moss K, Isenberg DA (2002) Outcome in patients with idiopathic inflammatory myositis: morbidity and mortality. Rheumatology 41:22–26

    Article  PubMed  CAS  Google Scholar 

  36. Marie I, Hachulla E, Hatron PY, Hellot MF, Levesque H, Devulder B et al (2001) Polymyositis and dermatomyositis: short term and long term outcome, and predictive factors of prognosis. J Rheumatol 28:2230–2237

    PubMed  CAS  Google Scholar 

  37. Reinhold-Keller E, Beuge N, Latza U, Kirsten de Groot, Rudert H et al (2000) An interdisciplinary approach to the care of patients with Wegener’s granulomatosis. Arthritis Rheum 43:1021–1032

    Article  PubMed  CAS  Google Scholar 

  38. Anderson G, Coles ET, Crane M, Douglas AC, Gibbs AR, Geddes D et al (1992) Wegener’s granuloma. A series of 265 British cases seen between 1975 and 1985. A report by a sub-committee of the British Thoracic Society Research Committee. Q J Med 83:427–438

    PubMed  CAS  Google Scholar 

  39. Hoffmann GS, Kerr G, Leavitt R, Hallahan CW, Lebovics RS, Travis W et al (1992) Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 116:488–498

    Google Scholar 

  40. RuangJutipopan S, Kasitanon N, Louthrenoo W, Sukitawut W, Wichainun R (2002) Causes of death and poor prognostic factors in Thai patients with systemic sclerosis. J Med Assoc Thai 85:1204–1209

    PubMed  Google Scholar 

  41. Ward MM, Donald F (1999) Pneumocystis carinii pneumonia in patients with connective tissue diseases: the role of hospital experience in diagnosis and mortality. Arthritis Rheum 42:780–789

    Article  PubMed  CAS  Google Scholar 

  42. Kadoya A, Okada J, Iikuni Y, Kondo H (1996) Risk factor for Pneumocystis carinii pneumonia in patients with polymyositis/dermatomyositis or systemic lupus erythematosus. J Rheumatol 23:1186–1188

    PubMed  CAS  Google Scholar 

  43. Sneller MC, Hoffman GS, Talar-Williams C, Kerr GS, Hallahan CW, Fauci AS (1995) An analysis of forty-two Wegener’s granulomatosis patients treated with methotrexate and prednisone. Arthritis Rheum 38:608–613

    Article  PubMed  CAS  Google Scholar 

  44. Ognibene FP, Shelhamer JH, Hoffman GS, Kerr GS, Reda D, Fauci AS et al (1995) Pneumocystis carinii pneumonia: a major complication of immunosuppressive therapy in patients with Wegener’s granulomatosis. Am J Respir Crit Care Med 151:795–799

    PubMed  CAS  Google Scholar 

  45. Godeau B, Coutant-Perronne V, Le Thi Huong D, Guillevin L, Magadur G, De Bandt M et al (1994) Pneumocystis carinii pneumonia in the course of connective tissue disease: report of 34 cases. J Rheumatol 21:246–251

    PubMed  CAS  Google Scholar 

  46. Sowden E, Carmichael AJ (2004) Autoimmune inflammatory disorders and pneumocystis pneumonia: a strategy for prevention. BMC Infect Dis 4:42

    Article  PubMed  CAS  Google Scholar 

  47. Juarez M, Misischia R, Alarcon GS ( 2003) Infections in systemic connective tissue diseases: systemic lupus erythematosus, scleroderma, and polymyositis/dermatomyositis. Rheum Dis Clin North Am 29:163–184

    Article  PubMed  Google Scholar 

  48. Doran F, Crowson CS, Pond GR, O’Fallon WM, Gabriel SE (2002) Frequency of infection in patients with rheumatoid arthritis compared with controls. Arthritis Rheum 46:2287–2293

    Article  PubMed  Google Scholar 

  49. Mutru O, Laakso M, Isomaki H, Koota K (1985) Ten year mortality and causes of death in patients with rheumatoid arthritis. Br Med J 290:1797–1799

    Article  CAS  Google Scholar 

  50. Wolfe F, Mitchell DM, Sibley JT, Fries JF, Bloch DA, Williams CA et al (1994) The mortality of rheumatoid arthritis. Arthritis Rheum 37:481–494

    Article  PubMed  CAS  Google Scholar 

  51. Staples PJ, Gerding DN, Decker JL, Gordon RS Jr (1974) Incidence of infection in systemic lupus erythematosus. Arthritis Rheum 17:1–10

    Article  PubMed  CAS  Google Scholar 

  52. Jarrousse B, Guillevin L, Bindi P, Hachulla E, Leclerc P, Gilson B et al (1993) Increased risk of Pneumocystis carinii pneumonia in patients with Wegener’s granulomatosis. Clin Exp Rheumatol 11:615–621

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Alfa Institute of Biomedical Sciences (AIBS), 9 Neapoleos Street, 151 23 Marousi, Athens, Greece

    Matthew E. Falagas, Katerina G. Manta & Gregoria I. Betsi

  2. Department of Medicine, Tufts University School of Medicine, Boston, MA, USA

    Matthew E. Falagas

  3. Department of Medicine, Henry Dunant Hospital, Athens, Greece

    Matthew E. Falagas

  4. Institute for Continuing Medical Education of Ioannina, Ioannina, Greece

    Georgios Pappas

Authors
  1. Matthew E. Falagas
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Katerina G. Manta
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gregoria I. Betsi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Georgios Pappas
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Matthew E. Falagas.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Falagas, M.E., Manta, K.G., Betsi, G.I. et al. Infection-related morbidity and mortality in patients with connective tissue diseases: a systematic review. Clin Rheumatol 26, 663–670 (2007). https://doi.org/10.1007/s10067-006-0441-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-006-0441-9

Keywords

Search

Navigation